search
Back to results

A Comparison of the Effect of Warm and Cold Water Exercise Training on Vascular Function in Type 2 Diabetic Patients

Primary Purpose

Type 2 Diabetes

Status
Completed
Phase
Not Applicable
Locations
Thailand
Study Type
Interventional
Intervention
Warm water exercise
Cold water exercise
Land based cycling exercise
Sponsored by
Chulalongkorn University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes focused on measuring Type 2 Diabetes, Vascular Function, Water Exercise, Warm Water, Cold Water

Eligibility Criteria

60 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The inclusion criteria included type 2 diabetes (as defined by the American Diabetes Association), a baseline glycosylated hemoglobin (HbA1c) value of 7-9%, and no previous exercise training in the past 6 months. All participants were free from diabetic nephropathy, diabetic retinopathy, severe diabetic neurophathy, severe cardiovascular and cerebrovascular diseases.

Exclusion Criteria:

  • Participants were excluded if they dropped out or completed less than 80% of the training schedule.

Sites / Locations

  • Laemchabang stadium, Sukhumvit Rd

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Warm water exercise & Cold water exercise

Warm water exercise & Land cycling exercise

Arm Description

Outcomes

Primary Outcome Measures

Change from baseline in glycemic control
The glycemic control will be quantified using blood samples. Fasting blood glucose, HbA1c, insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and C-reactive protein will be measured with standard procedures at the clinical laboratory (N health Lab, Samitivej, Sriracha, Thailand). Homeostasis model assessment (HOMA-IR will be calculated by using equation of [Fasting glucose (mg/dL) × Insulin level (uU/mL) / 405].
Change from baseline in vascular reactivity
Vascular reactivity or brachial and popliteal artery flow-mediated dilatation (FMD) will be assessed with the ultrasound equipment (CX50, Philips, USA), using the blood occlusion technique on the right forearm and lower leg. The brachial artery and the popliteal artery will be imaged above the antecubital fossa in the longitudinal plane and proximal slightly above the popliteal fossa. Brachial FMD will be measured at baseline and the cuff placed around the right forearm will be inflated to 50 mmHg above systolic blood pressure for 5 minutes and then deflated for 5 minutes of recovery. While popliteal FMD will be measured at baseline and the cuff will be positioned on the lower right leg below the knee will be inflated to 250 mmHg for 5 minutes and then deflated for 5 minutes of recovery. FMD will be calculated from the formula FMD= (D2-D1)x100/D1 when D1 is the brachial or popliteal artery diameter at baseline, D2 is the maximal post-occlusion brachial or popliteal artery diameter.
Change from baseline in cutaneous blood flow
Cutaneous blood flow will be determined by laser Doppler Flowmetry (DRT4, Moore Instrument, UK). Laser Doppler Flowmetry probes will be attached to the dorsum of middle fingertip and the dorsum of the foot. The occlusion cuffs will be placed around left middle upper arm and calf were inflated to a pressure of 50 mmHg above the systolic pressure and will be remained inflated for 3 minutes, after which it will be rapidly released, producing a brief high-flow state resulting in artery dilation due to increase shear stress. The peak Laser Doppler Flux (peak LDF) and after 5 min occlusion period will be recorded.

Secondary Outcome Measures

Change from baseline in physical fitness
Body composition will be measured using Body Composition Analyzer (Tanita BC-533, Japan)
Change from baseline in physical fitness
Lower muscle strength will be measured with leg dynamometer (Tokyo, Japan).
Change from baseline in physical fitness
Maximal oxygen consumption (VO2peak) will be assessed by bicycle ergometer (Monark: 824e, Sweden). Initial work load was 50 watt and increased stepwise by 25 W every 2 minutes (as measured using respiratory gas analyzer: Metamax 3B, Germany) until the subjects were no longer able to continue exercising.
Change from baseline in physical fitness
Pulmonary function will be measured by spirometer ((MIR-Spirobank G)
Change from baseline in blood chemistry
Nitric oxide (NO) will be measured in plasma samples with the commercial assay kit (Colorimetric nitric oxide assay kit, PromoKine, Germany).
Change from baseline in blood chemistry
Malondialdehyde (MDA) will be determined using thiobarbituric acid reaction.
Change from baseline in blood chemistry
C-reactive protein will be measured with standard procedures at the clinical laboratory (N health Lab, Samitivej, Sriracha, Thailand).
Change from baseline in Peripheral arterial stiffness
Pulse wave velocity (brachial-ankle PWV) measurement will be assessed using Omron Colin VP1000 for measuring.

Full Information

First Posted
September 15, 2015
Last Updated
April 3, 2018
Sponsor
Chulalongkorn University
search

1. Study Identification

Unique Protocol Identification Number
NCT02551900
Brief Title
A Comparison of the Effect of Warm and Cold Water Exercise Training on Vascular Function in Type 2 Diabetic Patients
Official Title
A Comparison of the Effect of Warm and Cold Water Exercise Training on Vascular Function in Type 2 Diabetic Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
September 1, 2014 (undefined)
Primary Completion Date
September 15, 2015 (Actual)
Study Completion Date
December 15, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chulalongkorn University

4. Oversight

5. Study Description

Brief Summary
Warm water based cycling exercise training would more favorable than cold water based cycling exercise training and land based cycling exercise in vascular function in type 2 diabetic patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
Keywords
Type 2 Diabetes, Vascular Function, Water Exercise, Warm Water, Cold Water

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
48 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Warm water exercise & Cold water exercise
Arm Type
Experimental
Arm Title
Warm water exercise & Land cycling exercise
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Warm water exercise
Intervention Description
Warm water based cycling exercise training program will be based on cycling in warm water (temperature 34◦C ). Warm water exercise will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.
Intervention Type
Other
Intervention Name(s)
Cold water exercise
Intervention Description
Cold water based cycling exercise training will be based on cycling in cold water (temperature 20◦C ). Cold water exercise will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.
Intervention Type
Other
Intervention Name(s)
Land based cycling exercise
Intervention Description
Land based cycling exercise training will be based on ride a bicycle ergometer (Monark 894e, Sweden). Land based cycling exercise training will be conducted at moderate intensity (60-70% maximum heart rate). The three groups were exercise 15 minutes on the first month, second month will be increased to 20 minutes and the last month will be increased to 30 minutes. The training program will be performed 3 times per week for 12 weeks.
Primary Outcome Measure Information:
Title
Change from baseline in glycemic control
Description
The glycemic control will be quantified using blood samples. Fasting blood glucose, HbA1c, insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and C-reactive protein will be measured with standard procedures at the clinical laboratory (N health Lab, Samitivej, Sriracha, Thailand). Homeostasis model assessment (HOMA-IR will be calculated by using equation of [Fasting glucose (mg/dL) × Insulin level (uU/mL) / 405].
Time Frame
Baseline, 12 weeks
Title
Change from baseline in vascular reactivity
Description
Vascular reactivity or brachial and popliteal artery flow-mediated dilatation (FMD) will be assessed with the ultrasound equipment (CX50, Philips, USA), using the blood occlusion technique on the right forearm and lower leg. The brachial artery and the popliteal artery will be imaged above the antecubital fossa in the longitudinal plane and proximal slightly above the popliteal fossa. Brachial FMD will be measured at baseline and the cuff placed around the right forearm will be inflated to 50 mmHg above systolic blood pressure for 5 minutes and then deflated for 5 minutes of recovery. While popliteal FMD will be measured at baseline and the cuff will be positioned on the lower right leg below the knee will be inflated to 250 mmHg for 5 minutes and then deflated for 5 minutes of recovery. FMD will be calculated from the formula FMD= (D2-D1)x100/D1 when D1 is the brachial or popliteal artery diameter at baseline, D2 is the maximal post-occlusion brachial or popliteal artery diameter.
Time Frame
Baseline, 12 weeks
Title
Change from baseline in cutaneous blood flow
Description
Cutaneous blood flow will be determined by laser Doppler Flowmetry (DRT4, Moore Instrument, UK). Laser Doppler Flowmetry probes will be attached to the dorsum of middle fingertip and the dorsum of the foot. The occlusion cuffs will be placed around left middle upper arm and calf were inflated to a pressure of 50 mmHg above the systolic pressure and will be remained inflated for 3 minutes, after which it will be rapidly released, producing a brief high-flow state resulting in artery dilation due to increase shear stress. The peak Laser Doppler Flux (peak LDF) and after 5 min occlusion period will be recorded.
Time Frame
Baseline, 12 weeks
Secondary Outcome Measure Information:
Title
Change from baseline in physical fitness
Description
Body composition will be measured using Body Composition Analyzer (Tanita BC-533, Japan)
Time Frame
Baseline, 12 weeks
Title
Change from baseline in physical fitness
Description
Lower muscle strength will be measured with leg dynamometer (Tokyo, Japan).
Time Frame
Baseline, 12 weeks
Title
Change from baseline in physical fitness
Description
Maximal oxygen consumption (VO2peak) will be assessed by bicycle ergometer (Monark: 824e, Sweden). Initial work load was 50 watt and increased stepwise by 25 W every 2 minutes (as measured using respiratory gas analyzer: Metamax 3B, Germany) until the subjects were no longer able to continue exercising.
Time Frame
Baseline, 12 weeks
Title
Change from baseline in physical fitness
Description
Pulmonary function will be measured by spirometer ((MIR-Spirobank G)
Time Frame
Baseline, 12 weeks
Title
Change from baseline in blood chemistry
Description
Nitric oxide (NO) will be measured in plasma samples with the commercial assay kit (Colorimetric nitric oxide assay kit, PromoKine, Germany).
Time Frame
Baseline, 12 weeks
Title
Change from baseline in blood chemistry
Description
Malondialdehyde (MDA) will be determined using thiobarbituric acid reaction.
Time Frame
Baseline, 12 weeks
Title
Change from baseline in blood chemistry
Description
C-reactive protein will be measured with standard procedures at the clinical laboratory (N health Lab, Samitivej, Sriracha, Thailand).
Time Frame
Baseline, 12 weeks
Title
Change from baseline in Peripheral arterial stiffness
Description
Pulse wave velocity (brachial-ankle PWV) measurement will be assessed using Omron Colin VP1000 for measuring.
Time Frame
Baseline, 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The inclusion criteria included type 2 diabetes (as defined by the American Diabetes Association), a baseline glycosylated hemoglobin (HbA1c) value of 7-9%, and no previous exercise training in the past 6 months. All participants were free from diabetic nephropathy, diabetic retinopathy, severe diabetic neurophathy, severe cardiovascular and cerebrovascular diseases. Exclusion Criteria: Participants were excluded if they dropped out or completed less than 80% of the training schedule.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daroonwan Suksom, Ph.D.
Organizational Affiliation
Faculty of Sport Science Chulalongkorn University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Laemchabang stadium, Sukhumvit Rd
City
Si Racha
State/Province
Chon Buri
ZIP/Postal Code
20230
Country
Thailand

12. IPD Sharing Statement

Learn more about this trial

A Comparison of the Effect of Warm and Cold Water Exercise Training on Vascular Function in Type 2 Diabetic Patients

We'll reach out to this number within 24 hrs